Encelta Company
Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2023-03-10
Industry:
Cell, Gene & Biologics Therapeutics
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Investors:
Innosuisse
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland